...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products:(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2(Date:10/10/2008)...- TriReme Medical Inc. (TMI),announced today that ...,Europeenne) marking and commercialize in Europe t...n vessel stent system specially designed for use,a...e next generation in bifurcation stenting, the,Ant...the 2.2 million,angioplasty procedures performed a...
(Date:10/9/2008)...o protect the eyesight of,older people, NEW YORK,...orldwide who,are blind, 80 percent are over age 50...eir blindness if they had been properly diagnosed ... go to:, http://www.prnewswire.com/mnr/orbis/35257...s and equipment, is,partnering with nonprofit ORBI...
(Date:10/9/2008)...mber 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fir...ced today the completion of patient enrollment and...to evaluate the safety and,efficacy of its formula...r,the over-the-counter (OTC) market. The Company e...l trial in November 2008. Ibuprofen is an analgesi...
(Date:10/9/2008).../ -- Diamyd Medical reports,that the world,s most ...al,of Medicine, has published an article with resu...etes vaccine for type 1 diabetes., (Logo: http:/... The article is now available on the journal,s web... on October 30. It presents the,results of the con...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Dr Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers 18794 1Dr Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers 18794 2Metametrix Introduces the New Neopterin Biopterin Profile 18789 1Metametrix Introduces the New Neopterin Biopterin Profile 18789 2IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance 5226 1IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance 5226 2IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance 5226 3Do antidepressants enhance immune function 3F 18782 1Do antidepressants enhance immune function 3F 18782 2...ay 23, 2007 - Cytogen,Corporation (NASDAQ: CYTO) t...ng the utility of its ProChart(TM) database to hel...oxidoreductase,(WWOX), an important tumor suppress..., lung, pancreatic, esophageal, and gastric,cancer...online,edition (25 April 2007) of the Journal of C...
...RNewswire-FirstCall/ --,Pharmacyclics, Inc. announ...bstract regarding Xcytrin(R) (motexafin gadolinium...se 3 SMART (Study,of Neurologic Progression with M...ata. The presentations and publications are part o...Clinical Oncology,Annual Meeting (ASCO) that will ...
Other Medicine Technology:Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 3Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 4Pharmacyclics Announces Presentations and Published Abstracts on,Xcytrin at The 2007 American Society of Clinical Oncology Annual,Meeting 2